Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -113.35% is 97% above its 5-year average of -3722.76%, near the high end of its 5-year range (-38200.00%–0.16%).
22.01% below its 12-month average of -92.90%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -48.14%.
OPERATING MARGIN
-113.35%
OPERATING MARGIN AVG TTM
-92.90%
OPERATING MARGIN AVG 3Y
-3264.37%
OPERATING MARGIN AVG 5Y
-3722.76%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-22.01%
CURRENT VS 3Y AVG
+96.53%
CURRENT VS 5Y AVG
+96.96%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 340 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
BridgeBio Pharma, Inc.
Market Cap
$12.95B
Operating Margin
-113.35%
TTM Avg
-92.90%
3Y Avg
-3264.37%
5Y Avg
-3722.76%
Market Cap
$12.89B
Operating Margin
10.15%
TTM Avg
12.77%
3Y Avg
11.89%
5Y Avg
11.41%
Market Cap
$13.19B
Operating Margin
0.77%
TTM Avg
13.08%
3Y Avg
19.11%
5Y Avg
24.45%
Market Cap
$12.52B
Operating Margin
-2.39%
TTM Avg
-1.31%
3Y Avg
-6.02%
5Y Avg
0.15%
Market Cap
$12.17B
Operating Margin
3.33%
TTM Avg
2.06%
3Y Avg
2.05%
5Y Avg
2.45%
Market Cap
$12.00B
Operating Margin
18.00%
TTM Avg
16.91%
3Y Avg
21.06%
5Y Avg
16.78%
Market Cap
$14.16B
Operating Margin
-18.92%
TTM Avg
-47.79%
3Y Avg
-341.06%
5Y Avg
-1987.98%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | $12.95B | -113.35% | -92.90% | -3264.37% | -3722.76% |
| ICON Public Limited Company (ICLR)vs › | $12.89B | 10.15% | 12.77% | 11.89% | 11.41% |
| Corcept Therapeutics Incorporated (CORT)vs › | $13.19B | 0.77% | 13.08% | 19.11% | 24.45% |
| Baxter International Inc. (BAX)vs › | $12.52B | -2.39% | -1.31% | -6.02% | 0.15% |
| Penumbra, Inc. (PEN)vs › | $12.49B | 12.45% | 10.35% | 7.09% | 3.40% |
| BrightSpring Health Services, Inc. Common Stock (BTSG)vs › | $12.17B | 3.33% | 2.06% | 2.05% | 2.45% |
| Encompass Health Corporation (EHC)vs › | $12.00B | 18.00% | 16.91% | 21.06% | 16.78% |
| Ascendis Pharma A/S (ASND)vs › | $14.16B | -18.92% | -47.79% | -341.06% | -1987.98% |
| DaVita Inc. (DVA)vs › | $11.47B | 15.06% | 15.52% | 13.94% | 14.32% |
| Bio-Techne Corporation (TECH)vs › | $11.36B | 20.73% | 14.55% | 18.31% | 20.93% |
Gross Margin
93.3%
Operating Margin
-113.3%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -48.14% |
| 2026-03-31 | -54.47% |
| 2025-12-31 | -120.14% |
| 2025-09-30 | -120.30% |
| 2025-06-30 | -121.45% |
| 2025-03-31 | -89.49% |
| 2024-12-31 | -3842.69% |
| 2024-09-30 | -7018.67% |
| 2024-06-30 | -8096.82% |
| 2024-03-31 | 0.16% |
| 2023-12-31 | -10167.11% |
| 2023-09-30 | -3854.61% |
| 2023-06-30 | -8903.05% |
| 2023-03-31 | -6909.26% |
| 2022-12-31 | -6910.80% |
| 2022-09-30 | -38200.00% |
| 2022-06-30 | -108.72% |
| 2022-03-31 | -10252.54% |
| 2021-12-31 | -1285.22% |
| 2021-09-30 | -6377.94% |
| 2021-06-30 | -174.02% |
| 2021-03-31 | -36256.28% |
| 2020-12-31 | -104499.18% |
| 2020-09-30 | -1475.81% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | -569.06% |
| 2019-09-30 | -203.93% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
